PlainPharmaWatch

CMS Open Payments · Program Year 2024

Minnesota

Minnesota received $50,051,744.72 in pharmaceutical-industry payments to 8,145 physicians and 19 teaching hospitals across 67,008 transactions.

$50.1M
Total payments
$46.9M
To physicians
$1.6M
To teaching hospitals
#20
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $50.1M in payments to 8,145 physicians and 19 teaching hospitals in Minnesota. That ranks Minnesota #20 of 59 states and territories (0.4% of the US total), averaging $5.8K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Minnesota pairs above-median payment volume with an overwhelmingly physician-directed payment mix.

#20
of 59 states
0.4%
of the national total
93.7%
to physicians vs. hospitals
8,145
physicians paid

What the Data Shows for Minnesota

Minnesota's Open Payments file is physician-weighted: 93.7% of $50.1M went to 8,145 physicians ($5.8K each), with 3.1% on 19 teaching hospitals.

On the national dollar ranking it is still #20 of 59 (0.4% of US payments). Average transaction $746.95. Leading nature of payment: "Royalty or License" at $18.0M (36.0% of the state file; top-three natures 70.0%).

Minnesota sits in the 68th percentile (mid-pack). Just above: Maryland ($54.7M). Just below: Indiana ($49.5M). For context: top-ranked California ($342.4M) is 6.8× larger than Minnesota. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Minnesota are distributed between physicians and teaching hospitals.

Physician Payments

$46.9M

93.7% of total · 8,145 recipients · $5.8K avg

Teaching Hospital Payments

$1.6M

3.1% of total · 19 hospitals · $82.7K avg

Payment Breakdown by Type

Minnesota has 16 types of pharmaceutical payments. "Royalty or License" accounts for 36.0%.

Nature concentration in Minnesota

Top three Open Payments natures are 70.0% of state dollars; residual is every other reported nature

Royalty or License$18.0MConsulting Fee$10.8MCompensation for Services Ot…$6.2MAll other natures (13)$15.0M

Payment categories in Minnesota

Top categories by total reported dollar volume

1. Royalty or License$18.0M2. Consulting Fee$10.8M3. Compensation for Services…$6.2M4. Acquisitions$5.2M5. Travel and Lodging$3.6M6. Food and Beverage$2.3M7. Education$897.0K8. Long-Term Medical Supply …$808.6K9. Grant$748.5K10. Honoraria$510.6K
Payment Type Amount Transactions
Royalty or License $18.0M 291
Consulting Fee $10.8M 3,968
Compensation for Services Other Than Consulting $6.2M 2,565
Acquisitions $5.2M 8
Travel and Lodging $3.6M 10,270
Food and Beverage $2.3M 47,025
Education $897.0K 1,486
Long-Term Medical Supply or Device Loan $808.6K 174
Grant $748.5K 108
Honoraria $510.6K 216
Space Rental or Facility Fees $486.6K 161
Compensation for Faculty or Speaker (Medical Education) $306.1K 170
Gift $72.5K 487
Debt Forgiveness $67.7K 34
Entertainment $4.7K 43
Charitable Contribution $2.5K 2

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Minnesota totals can and cannot tell you

The aggregate payment figure for Minnesota measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Minnesota's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.